AusDoc website
  • News
  • Opinion
  • Jobs
    Login Join
    AusDoc website
    AusDoc website
    • Login
    • Create an account
    • About Us
    • Advertise
    • Contact us
    • Privacy
    • Terms and Conditions

    Tag: Endocrinology – Diabetes

    Empagliflozin added to PBS for CKD, with or without diabetes

    April 4, 2024

    Adults with proteinuric chronic kidney disease can now access PBS-subsidised empagliflozin, regardless of their diabetes status, in addition to standard care. On Monday, 10mg empagliflozin…

    Doctor who reported semaglutide compounder ‘disappointed’ it took news exposé for TGA to act

    April 2, 2024

    A doctor who received warm compounded semaglutide that she refused to inject says it is disappointing it took an ABC exposé to jump-start a TGA investigation…

    Axillary rash reveals a patient’s diabetes danger

    March 23, 2024

    Geoff, a 79-year-old retiree, is a long-term aged care resident. The nursing staff report that he has had a red rash in both axillae for…

    Associate Professor Ralph Audehm

    ‘A game changer’: TGA approves diabetes drug for CKD

    February 22, 2024

    The TGA has approved empagliflozin to prevent chronic kidney disease progression in adults regardless of diabetes status, in addition to standard care. Under the expanded…

    Endocrinologist calls for earlier use of tirzepatide in T2DM patients

    February 16, 2024
    Watch this video for updated guidance on both new and established therapies for type 2 diabetes

    Dr Nick Coatsworth joins GP telehealth company offering compounded semaglutide for weight loss

    January 10, 2024

    The $100 million GP telehealth corporate Eucalyptus has recruited former deputy chief medical officer Dr Nick Coatsworth as a clinical governance adviser. The company recently…

    Out now! Updated prescribing tool for type 2 diabetes

    January 10, 2024
    An indispensable guide for simplifying treatment in the 'twincretin' era

    The tirzepatide story so far: an expert analysis

    December 6, 2023
    Demand is already outstripping supply for this novel type 2 diabetes drug

    GPs allowed to approve continuous glucose monitors — but only for veterans

    December 5, 2023

    GPs can now approve fully funded continuous glucose monitors for veteran card holders despite their ban from approving the devices under the National Diabetes Services…

    ‘Be wary of prescribing’ tirzepatide amid another diabetes drug shortage

    December 1, 2023

    Doctors should exercise caution when prescribing tirzepatide, a leading GP says, after a surge in demand sparked a supply shortage within two months of entering…

    Load More

    Login or join to access the full article

    Login or Join

    Latest Articles

    Loading...
    • Home
    • Articles
    • Jobs
    • More

    Loading...

    ‘Be wary of prescribing' tirzepatide amid another diabetes drug shortage

    Report

    There was a problem reporting this post.

    Harassment or bullying behavior
    Contains mature or sensitive content
    Contains misleading or false information
    Contains abusive or derogatory content
    Content that breaches the privacy of other individuals
    Contains spam, fake content or potential malware

    Block Member?

    Please confirm you want to block this member.

    You will no longer be able to:

    • See blocked member's posts
    • Mention this member in posts
    • Message this member
    • Add this member as a connection

    Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

    Report

    You have already reported this .